Cell News and Research

RSS

New research shows reduced toxicant exposure reduces biological activity

Two newly published studies from Imperial Brands scientists have provided further evidence that products associated with lower levels of combustion-related toxicants also produce substantially lower levels of combustion-related toxicants also produce substantially lower biological activity than cigarette smoke under laboratory conditions.

13 Oct 2026

Undecimal Bio launches with $18 million oversubscribed seed financing to address ‘liver trap’ in siRNA therapeutic delivery

Undecimal Bio, a platform biotechnology company advancing targeted delivery of siRNA therapeutics, today announced an oversubscribed $18 million USD seed financing.

From UndecimalBio 13 Oct 2026

Yokogawa brings publication-backed validation from more than 60,000 scientific publications to its CSU spinning disk confocal systems with Bioz

Through Bioz Badges, Yokogawa transforms its extensive publication history into a valuable resource for researchers evaluating advanced microscopy technologies.

From Yokogawa Life Science 13 Oct 2026

Scientists pinpoint key hotspot driving tau propagation in dementia

Diseases such as Alzheimer's and frontotemporal dementia are considered neurodegenerative tauopathies, in which tau proteins in the brain misfold and lead to cognitive decline.

12 Oct 2026

Study identifies Piezo channels as targets for orthodontic care

A new review in Genes & Diseases highlights Piezo channels as important biological links between mechanical forces and the cellular processes that shape the face, move teeth and influence oral health.

12 Oct 2026

Long non-coding RNAs offer new pathways to overcome cancer treatment resistance

Scientists are highlighting long non-coding RNAs (lncRNAs) as promising targets in the effort to overcome one of cancer treatment's most persistent challenges: therapeutic resistance.

12 Oct 2026

RNA modification enzyme FTO shows therapeutic promise in gastrointestinal cancers

A new review in Genes & Diseases highlights FTO, an enzyme involved in RNA modification, as a potentially important biomarker and therapeutic target across gastrointestinal cancers.

12 Oct 2026

Review highlights EP4 receptor as target for inflammatory diseases

A review published in Genes & Diseases highlights the prostaglandin E2 receptor subtype 4 (EP4) as an important regulator of inflammation and a promising therapeutic target for a wide range of inflammatory and inflammation-related diseases.

12 Oct 2026

Targeting mitochondrial vulnerabilities could help treat triple-negative breast cancer

A deeper understanding of mitochondrial function could create new opportunities for treating triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of breast cancer.

12 Oct 2026

Targeting lipophagy could help treat metabolic and oxidative stress-related diseases

A review published in Genes & Diseases highlights lipophagy, the cellular process that selectively breaks down lipid droplets, as a potentially important therapeutic target for conditions driven by disrupted lipid metabolism and oxidative stress.

12 Oct 2026

New review highlights expanding potential of therapeutic DNA vaccines

A new review published in Genes & Diseases highlights the expanding potential of DNA-based vaccines as a flexible platform for preventing infectious diseases, treating cancer and strengthening preparedness for future disease outbreaks.

12 Oct 2026

Buck Institute and Georgetown lead effort mapping harmful protein changes before disease begins

A research "super team" co-led by theBuck Institute for Research on Aging and Georgetown University has received an award of up to $51.7 million from the Advanced Research Projects Agency for Health (ARPA-H) to predict how disease-causing proteins misfold before irreversible damage occurs and use those predictions to develop novel diagnostics and treatments.

12 Oct 2026

Vascular anatomy influences experimental stroke treatment effectiveness

A preclinical study from Duke University researchers suggests that the effectiveness of an experimental approach to limiting stroke-related brain injury may depend not only on the drug itself, but also on the brain's collateral circulation: the network of small "backup" blood vessels that can help sustain tissue when a major artery is blocked.

12 Oct 2026

Three-dimensional genome structure shapes complex traits in cephalopods

Octopuses, squid and cuttlefish, collectively known as coleoid cephalopods, have evolved exceptionally large and elaborately structured nervous systems capable of complex behaviours such as problem-solving and rapid camouflage.

12 Oct 2026

Study reveals how different plant saponins alleviate ischemic stroke

Ischemic stroke accounts for approximately 85% of all strokes and remains a major cause of death and long-term disability.

12 Oct 2026

New AI system accelerates rabies virus detection in cell cultures

Rabies virus detection in cell cultures could soon become faster and more accessible, thanks to a world-first AI system developed by researchers at the University of Surrey's Institute for People-Centred AI (PAI) in collaboration with the Rabies and Viral Zoonoses team at the Animal and Plant Health Agency (APHA).

12 Oct 2026

Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia

Amphista Therapeutics Limited ('Amphista'), a leader in the discovery and development of non-cereblon / VHL targeted protein degradation (TPD) medicines, today announced dosing of the first patient in a Phase 1 trial for its lead candidate, AMX-883. Initiated following authorization from the U.S. Food and Drug Administration in June 2026, the BRAMLIE trial will investigate the safety, pharmacokinetics, and preliminary efficacy of AMX-883 monotherapy in participants with AML and high-risk MDS.

From Amphista Therapeutics 12 Oct 2026

A study links a blood protein to memory and brain changes in Down syndrome

Researchers studying 88 adults with Down syndrome and 43 controls estimated that serum β-synuclein increased approximately two decades before expected Alzheimer’s symptoms, preceding changes in other blood biomarkers. Higher levels correlated with poorer memory and brain changes, but the cross-sectional study could not distinguish whether the earliest increase reflected Alzheimer’s-related synaptic dysfunction, trisomy 21-related neurobiology, or both.

11 Oct 2026

Scientists identify the neuroblastoma cells that signal poor outcomes

Neuroblastoma is the most common solid tumor found outside of the brain in children, yet why some children respond well to treatment while others do not has remained poorly understood.

10 Oct 2026

A trick from tardigrades could help human blood withstand freezing

Tardigrades, also called water bears, are famous for their ability to survive nearly anything. They protect themselves in extreme environments using proteins that researchers have developed into an efficient and effective strategy to preserve human red blood cells.

10 Oct 2026

Previous
1
...
11
12
13
14
15
16
17
...
4186
Next

Cell News and Research

New research shows reduced toxicant exposure reduces biological activity

Undecimal Bio launches with $18 million oversubscribed seed financing to address ‘liver trap’ in siRNA therapeutic delivery

Yokogawa brings publication-backed validation from more than 60,000 scientific publications to its CSU spinning disk confocal systems with Bioz

Scientists pinpoint key hotspot driving tau propagation in dementia

Study identifies Piezo channels as targets for orthodontic care

Long non-coding RNAs offer new pathways to overcome cancer treatment resistance

RNA modification enzyme FTO shows therapeutic promise in gastrointestinal cancers

Review highlights EP4 receptor as target for inflammatory diseases

Targeting mitochondrial vulnerabilities could help treat triple-negative breast cancer

Targeting lipophagy could help treat metabolic and oxidative stress-related diseases

New review highlights expanding potential of therapeutic DNA vaccines

Buck Institute and Georgetown lead effort mapping harmful protein changes before disease begins

Vascular anatomy influences experimental stroke treatment effectiveness

Three-dimensional genome structure shapes complex traits in cephalopods

Study reveals how different plant saponins alleviate ischemic stroke

New AI system accelerates rabies virus detection in cell cultures

Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia

A study links a blood protein to memory and brain changes in Down syndrome

Scientists identify the neuroblastoma cells that signal poor outcomes

A trick from tardigrades could help human blood withstand freezing

Improve fermentation and cell culture performance with real-time gas analysis eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery